Tepotinib in patients with advanced non-small lung cancer (NSCLC) and MET exon 14-skipping mutations: Phase II data

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 29; p. ix152
Main Authors Sakai, H., Felip, E., Cortot, A.B., Veillon, R., Griesinger, F., Patel, J., Horn, L., Mazieres, J., De Castro Carpeno, J., Morise, M., Sakamoto, T., Bruns, R., Scheele, J., Straub, J., Paik, P.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.11.2018
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdy425.004